Literature DB >> 1894362

Construction and expression of plasmids containing mutated diphtheria toxin A-chain-coding sequences.

K S Fisher1, I H Maxwell, J R Murphy, J Collier, L M Glode.   

Abstract

We previously demonstrated that cells can be killed through transfection of an expression plasmid that encodes the diphtheria toxin A-chain fragment (DT-A). This report describes the construction of expression plasmids containing three mutant DT-A-coding sequences substituting glutamic acid 148 with aspartic acid, serine, or glutamine which are known to have 100- to 300-fold-reduced ADP-ribosylation activity measured in vitro. The toxicity of these constructs was determined in cotransfection experiments using HeLa and 293 cells with a luciferase expression plasmid as the reporter. Dose responses were compared for the three new DT-A mutant plasmids and for the corresponding plasmids containing wild-type DT-A and the previously characterized tox 176 mutant. The dose required to produce 50% inhibition of control luciferase expression in 293 embryonic kidney cells for the five plasmids ranged from 0.01 micrograms for wild-type DT-A to 1.2 micrograms for the least toxic plasmid, which replaces glutamic acid 148 with glutamine. In conclusion, a wide range of DT-A toxicity can be achieved by using plasmid expression vectors that encode different DT-A mutations.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1894362      PMCID: PMC258921          DOI: 10.1128/iai.59.10.3562-3565.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Transient gene expression control: effects of transfected DNA stability and trans-activation by viral early proteins.

Authors:  J C Alwine
Journal:  Mol Cell Biol       Date:  1985-05       Impact factor: 4.272

Review 2.  Bacterial toxins and the role of ADP-ribosylation.

Authors:  K A Wreggett
Journal:  J Recept Res       Date:  1986

3.  Using mini-prep plasmid DNA for sequencing double stranded templates with Sequenase.

Authors:  R Kraft; J Tardiff; K S Krauter; L A Leinwand
Journal:  Biotechniques       Date:  1988-06       Impact factor: 1.993

4.  Diphtheria toxin. Effect of substituting aspartic acid for glutamic acid 148 on ADP-ribosyltransferase activity.

Authors:  R K Tweten; J T Barbieri; R J Collier
Journal:  J Biol Chem       Date:  1985-09-05       Impact factor: 5.157

5.  Cloning, sequence determination, and expression in transfected cells of the coding sequence for the tox 176 attenuated diphtheria toxin A chain.

Authors:  F Maxwell; I H Maxwell; L M Glode
Journal:  Mol Cell Biol       Date:  1987-04       Impact factor: 4.272

6.  DNA sequence analysis with a modified bacteriophage T7 DNA polymerase.

Authors:  S Tabor; C C Richardson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

7.  Regulated expression of a diphtheria toxin A-chain gene transfected into human cells: possible strategy for inducing cancer cell suicide.

Authors:  I H Maxwell; F Maxwell; L M Glode
Journal:  Cancer Res       Date:  1986-09       Impact factor: 12.701

8.  Active-site mutations of diphtheria toxin: effects of replacing glutamic acid-148 with aspartic acid, glutamine, or serine.

Authors:  B A Wilson; K A Reich; B R Weinstein; R J Collier
Journal:  Biochemistry       Date:  1990-09-18       Impact factor: 3.162

9.  Firefly luciferase gene: structure and expression in mammalian cells.

Authors:  J R de Wet; K V Wood; M DeLuca; D R Helinski; S Subramani
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

10.  Cell lineage ablation in transgenic mice by cell-specific expression of a toxin gene.

Authors:  R D Palmiter; R R Behringer; C J Quaife; F Maxwell; I H Maxwell; R L Brinster
Journal:  Cell       Date:  1987-07-31       Impact factor: 41.582

View more
  1 in total

1.  Development of a nonintegrating Rev-dependent lentiviral vector carrying diphtheria toxin A chain and human TRAF6 to target HIV reservoirs.

Authors:  Z Wang; Z Tang; Y Zheng; D Yu; M Spear; S R Iyer; B Bishop; Y Wu
Journal:  Gene Ther       Date:  2010-04-22       Impact factor: 5.250

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.